Eksempler på brug af
Increased in patients
på Engelsk og deres oversættelser til Dansk
{-}
Medicine
Official
Colloquial
Financial
Ecclesiastic
Official/political
Computer
Malignancy The risk of malignancy is increased in patients with RA.
Malignitet Risikoen for malignitet er forhøjet hos patienter med reumatoid artrit.
Repaglinide exposure is increased in patients with hepatic insufficiency and in the elderly type 2 diabetic patients..
Repaglinid eksponering er øget i patienter med lever insufficiens og i de ældre type 2 diabetiske patienter..
Renal impairment The exposure of enalapril and enalaprilat is increased in patients with renal insufficiency.
Nyresvigt Eksponering for enalpril og enalaprilat øges for patienter med nyresvigt.
Mean Cmax was not increased in patients with mild renal impairment and increased by 12% in patients with moderate renal impairment.
Middel C max var ikke øget hos patienter med lettere nedsat nyrefunktion, og den var øget med 12% hos patienter med moderat nedsat nyrefunktion.
The risk of overall daytime hypoglycaemic episodes was increased in patients treated with NovoMix 30.
Risikoen for generelle hypoglykæmiske episoder i dagtimerne var øget hos patienter behandlet med NovoMix 30.
HBeAg seroconversion was increased in patients with elevated ALT levels; 77%(20/ 26) of patients with pre-treatment ALT> 2 x ULN seroconverted.
HBeAg- serokonversion var øget hos patienter med forhøjede ALAT- niveauer; 77%(20/ 26) patienter, med præ- behandling ALAT> 2 x ULN, serokonverterede.
The AUC of one pharmacologically active ranolazine metabolite was 5-fold increased in patients with severe renal impairment.
AUC for én farmakologisk aktiv ranolazin- metabolit var 5 gange højere hos patienter med svært nedsat nyrefunktion.
Efavirenz plasma exposure may be increased in patients with homozygous G516T genetic variant of the CYP2B6 isoenzyme.
Efavirenz plasmaeksponering kan øges hos patienter med homozygot- G516T, der er en genetisk variant af CYP2B6- isoenzymet.
When antitumor response also noted a decrease in the protein NF-kB1,whose activity is increased in patients with cancer.
Når antitumorreaktion bemærkede også et fald i protein NF-KB1,hvis aktivitet er øget i patienter med cancer.
Zidovudine concentrations are increased in patients with advanced renal failure.
Koncentrationen af zidovudin er øget hos patienter med fremskreden nyresvigt.
The risk of skin and mucous membrane bleeding, including gastrointestinal haemorrhage,may be increased in patients taking venlafaxine.
Risikoen for blødninger fra hud og slimhinder, herunder gastrointestinal blødning,kan forhøjes hos patienter, som tager venlafaxin.
The half-life of reteplase was increased in patients with AMI as compared to healthy volunteers.
Halveringtiden af reteplase var forøget hos patienter med AMI sammenlignet med raske forsøgspersoner.
The risk of worsening cardiovascular pathologies, diabetes, andpremature childbirth is increased in patients with untreated periodontitis.
Risiko for forværring af kardiovaskulære sygdomme, diabetes ogpræmatur børnefødsel er øget hos patienter med ubehandlet parodontitis.
Haematological toxicity was increased in patients receiving trastuzumab and docetaxel, compared with docetaxel alone 32% grade 3/ 4 neutropenia versus 22%, using NCI-CTC criteria.
Hæmatologisk toksicitet var forhøjet hos de patienter, som modtog trastuzumab og docetaxel, i forhold til de patienter som fik behandling med docetaxel alene 32% grad 3/ 4 neutropeni versus 22%, under anvendelse af NCI- CTC kriterierne.
In addition the VALIANT study demonstrated that mortality was not increased in patients receiving the triple combination.
Derudover viste VALIANT- undersøgelsen, at dødeligheden ikke steg hos patienter, der modtog den tredobbelte kombination.
Lasofoxifene clearance may be increased in patients chronically treated with inducers of CYP3A4 and UGTs(eg, phenytoin, carbamazepine, barbiturates and St John' s Wort) resulting in reduced steady-state concentrations and may result in reduced efficacy.
Clearance af lasofoxifen kan være øget hos patienter i kronisk behandling med inducere af CYP3A4 og UGT- enzymer(f. eks. phenytoin, carbamazepin, barbiturater og perikum), hvilket vil resultere i lavere steady state- koncentrationer og potentielt nedsat effekt.
Infact fractures of spine, hip andwrist are all increased in patients who take Arimidex for long periods.
Infact brud på rygsøjlen, hofte oghåndled er alle forhøjet hos patienter, der tager Arimidex i lange perioder.
Since the active metabolite of leflunomide, A771726, is highly protein bound and cleared via hepatic metabolism and biliary secretion,plasma levels of A771726 are expected to be increased in patients with hypoproteinaemia.
Da den aktive leflunomid- metabolit, A771726, er udtalt proteinbundet og udskilles via hepatisk metabolisme og biliær sekretion,kan det forventes, at plasmakoncentrationen af A771726 vil være øget hos patienter med hypoproteinæmi.
Infact fractures of spine, hip andwrist are all increased in patients who take Arimidex for long periods.
Infact brud på rygsà ̧jlen, hofte oghåndled er alle forhà ̧jet hos patienter, der tager Arimidex i lange perioder.
Compared with natural conception, the incidence of multiple pregnancies(mainly twins) and births is increased in patients undergoing this type of treatment.
Hos patienter som undergår denne type behandling, er muligheden for flerfoldig graviditet(hovedsagelig tvillinger) og fødsel øget, sammenlignet med naturlig befrugtning.
Lamivudine and zidovudine concentrations are increased in patients with renal impairment due to decreased clearance.
Koncentrationen af lamivudin og zidovudin er øget hos patienter med nedsat nyrefunktion som følge af nedsat clearance.
The exposure of lansoprazole is doubled in patients with mild hepatic impairment and much more increased in patients with moderate and severe hepatic impairment.
Eksponeringen for lansoprazol fordobles hos patienter med mildt nedsat leverfunktion og øges langt mere hos patienter med moderat og svært nedsat leverfunktion.
The elimination of toremifene andits metabolites was significantly increased in patients with activated liver function and decreased in patients with impaired liver function.
Eliminationen af toremifen ogdets metabolitter var signifikant øget hos patienter med aktiveret leverfunktion og nedsat hos patienter med nedsat leverfunktion.
Whilst no dosage adjustment of abacavir is necessary in patients with renal dysfunction, lamivudine andzidovudine concentrations are increased in patients with renal impairment due to decreased clearance.
Mens det ikke er nødvendigt med dosisjustering af abacavir hos patienter med nedsat nyrefunktion,er koncentrationerne af lamivudin og zidovudin øget hos patienter med nedsat nyrefunktion som følge af nedsat clearance.
The risk of severe myelotoxicity andlong-lasting immunosuppression is increased in patients with a disease-related bone marrow infiltration or a previous myelosuppressive treatment.
Risikoen for alvorlig myelotoksicitet oglangvarig immunsuppression er øget hos patienter med sygdomsrelateret knoglemarvsinfiltration eller en tidligere myelosuppressiv behandling.
After two to four weeks of taking Rasilez HCT,the dose can be increased in patients whose blood pressure remains uncontrolled.
Efter at have taget Rasilez HCT i to til fire uger,kan dosen øges hos patienter, hvis blodtryk fortsat ikke er under kontrol.
The incidence of febrile neutropenia/ neutropenic sepsis was also increased in patients treated with Herceptin plus docetaxel 23% versus 17% for patients treated with docetaxel alone.
Incidensen af febril neutropeni/ neutropenisk sepsis var også øget hos patienter behandlet med Herceptin plus docetaxel 23% versus 17% for patienter behandlet med docetaxel alene.
The exposure of the O-desmethyl metabolite was several-fold increased in patients with moderate and severe renal impairment.
Eksponeringen af O- desmethyl- metabolitten var forhøjet adskillige gange hos patienter med moderat og alvorlig nedsat nyrefunktion.
The incidence of febrile neutropenia/ neutropenic sepsis was also increased in patients treated with Herceptin plus docetaxel 23% versus 17% forpatients treated with docetaxel alone.
Forekomsten af febril neutropeni/ neutropenisk sepsis var også forhøjet hos de patienter, der fik behandling med Herceptin plus docetaxel 23% versus 17% for de patienter, der fik behandling med docetaxel alene.
Studies with lamivudine show that plasma concentrations(AUC) are increased in patients with renal dysfunction due to decreased clearance.
Forsøg med lamivudin viser at plasmakoncentrationer(AUC) øges hos patienter med nedsat nyrefunktion på grund af nedsat clearance.
Resultater: 2022,
Tid: 0.0586
Hvordan man bruger "increased in patients" i en Engelsk sætning
Their incidence is greatly increased in patients receiving carboplatin in combination.
Troponins are also increased in patients with heart failure and myocarditis.
The risk is increased in patients under age 24, he testified.
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
However, the number significantly increased in patients with crescentic GN (P=0.021).
Herein, cerebellar activity is increased in patients compared to healthy subjects.
Alkaline phosphatase and P were significantly increased in patients with HD.
BAFF levels were significantly increased in patients with LNB and OIND.
Mortality increased in patients without ITD as early glycemic variability increased.
The exposure to propranolol is increased in patients with hepatic impairment.
Hvordan man bruger "forhøjet hos patienter" i en Dansk sætning
Risikoen er desuden forhøjet hos patienter, der har eller har haft et alkohol- eller stofmisbrug og/eller patienter, der har udtalte personlighedsforstyrrelser.
Mitrokondrieantistof vil være forhøjet ved en primiær biliær cirrose, ANCA er ofte forhøjet hos patienter primær scleroserende cholangitis.
Det er nedsat hos patienter med hjerte-
insufficiens med venekongestion og forhøjet hos patienter med leversygdom.
Risikoen for udvikling af PDAC er betydeligt forhøjet hos patienter med HP, og den akkumulerede livstidsrisiko er rapporteret til 20-50% [3, 4, 9].
Risikoen er betydeligt forhøjet hos patienter med eGFR ≤ 30ml/min/1,73m2.
Blodniveauerne er forhøjet hos patienter med nyreinsufficiens.
Hyperkaliæmi
Forhøjet kalium i blodet, togrejse til italien Indholdsfortegnelse
Ses forhøjet hos patienter med nedsat nyrefunktion.
Det er muligt, at nettorisikoen for at få apopleksi er forhøjet hos
patienter, der har lakunær infarkt i anamnesen og tager atorvastatin 80 mg/dag.
Under deres undersøgelse fandt de, at niveauerne af disse krydsreaktive T-celler er signifikant forhøjet hos patienter med multipel sklerose.
Skatol er fundet forhøjet hos patienter med sklerose.
English
Deutsch
Español
Suomi
Français
Norsk
عربى
Български
বাংলা
Český
Ελληνικά
עִברִית
हिंदी
Hrvatski
Magyar
Bahasa indonesia
Italiano
日本語
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
Svenska
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt
中文